Diabetic Kidney Disease (DKD) Market Insights: Prevalence, Treatment, and Growth Projections to 2032

The global DKD market was valued at USD 2.89 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 4.9%, reaching USD 4.45 billion by 2032. Key drivers include increased awareness, the rising global diabetes population, advancements in early detection technologies, and pharmaceutical innovations. Emerging drugs continue to offer new opportunities for effective DKD management.

Diabetic Kidney Disease (DKD), also known as diabetic nephropathy, is a chronic kidney condition caused by prolonged diabetes, leading to damage in the kidneys' ability to filter waste products from the blood. Over time, this damage worsens, potentially resulting in end-stage renal disease (ESRD) if untreated. Key symptoms of DKD include fatigue, swelling in the legs, poor appetite, and nausea, often developing gradually over several years. Late-stage signs may include weakness, muscle cramps, and anemia.